DR REDDYS LABORATORIES Financial Statement Analysis
|
||
The Revenues of DR REDDYS LABORATORIES have increased by 13.11% YoY .
The Earnings Per Share (EPS) of DR REDDYS LABORATORIES has increased by 106.27 % YoY. |
REVENUES |
OPERATING MARGIN |
PROFIT AFTER TAX |
EPS |
ROCE |
DR REDDYS LABORATORIES Last 5 Annual Financial Results
[BOM: 500124|NSE : DRREDDY]
Consolidated | Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 |
---|---|---|---|---|---|
Revenues | ₹21,545 Cr | ₹19,048 Cr | ₹17,517 Cr | ₹15,448 Cr | ₹14,281 Cr |
Expenses | ₹17,778 Cr | ₹15,178 Cr | ₹15,047 Cr | ₹12,270 Cr | ₹11,930 Cr |
Operating Profit (Excl OI) | ₹3,767 Cr | ₹3,870 Cr | ₹2,470 Cr | ₹3,178 Cr | ₹2,351 Cr |
Other Income | ₹485 Cr | ₹291 Cr | ₹621 Cr | ₹338 Cr | ₹155 Cr |
Interest | ₹96 Cr | ₹97 Cr | ₹98 Cr | ₹89 Cr | ₹79 Cr |
Depreciation | ₹1,165 Cr | ₹1,229 Cr | ₹1,163 Cr | ₹1,135 Cr | ₹1,077 Cr |
Profit Before Tax | ₹3,061 Cr | ₹2,884 Cr | ₹1,886 Cr | ₹2,336 Cr | ₹1,350 Cr |
Profit After Tax | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr | ₹1,950 Cr | ₹912 Cr |
Consolidated Net Profit | ₹2,183 Cr | ₹1,952 Cr | ₹2,026 Cr | ₹1,950 Cr | ₹947 Cr |
Earnings Per Share (Rs) | ₹270.55 | ₹131.16 | ₹117.28 | ₹121.90 | ₹117.47 |
PAT Margin (%) | 18.27 | 10.13 | 10.25 | 11.57 | 12.62 |
ROE(%) | 21.36 | 11.93 | 11.82 | 13.76 | 14.75 |
ROCE(%) | 26.22 | 14.59 | 15.49 | 11.12 | 13.66 |
Total Debt/Equity(x) | 0.06 | 0.18 | 0.17 | 0.14 | 0.28 |
Key Financials |
||
Market Cap | : | ₹ 98,062.6 Cr |
Revenue (TTM) | : | ₹ 28,011.1 Cr |
Net Profit(TTM) | : | ₹ 5,563.2 Cr |
EPS (TTM) | : | ₹ 333.5 |
P/E (TTM) | : | 17.6 |
Industry Peers & Returns | 1W | 1M | 1Y |
DR REDDYS LABORATORIES | -7.4% | -4.8% | 22.7% |
SUN PHARMACEUTICAL INDUSTRIES | -1% | -7.2% | 56.8% |
CIPLA | -4.6% | -6.2% | 49.8% |
ZYDUS LIFESCIENCES | -2.9% | -3.9% | 94.8% |
DIVIS LABORATORIES | -4.1% | 1.1% | 19.8% |
MANKIND PHARMA | -6.3% | -7.6% | NA |
TORRENT PHARMACEUTICALS | -7.7% | -2.2% | 57% |
LUPIN | -4.3% | -0.9% | 129.3% |
AUROBINDO PHARMA | -3.4% | -0.9% | 89.6% |
DR REDDYS LABORATORIES Revenues
[BOM: 500124|NSE : DRREDDY]
Y-o-Y | 13.11 % |
5 Yr CAGR | 10.83 % |
Years | Revenues | % Change | |
---|---|---|---|
Mar2023 | ₹21,545 Cr | 13.11 | |
Mar2022 | ₹19,048 Cr | 8.74 | |
Mar2021 | ₹17,517 Cr | 13.39 | |
Mar2020 | ₹15,448 Cr | 8.17 | |
Mar2019 | ₹14,281 Cr | - |
DR REDDYS LABORATORIES Operating Profit
[BOM: 500124|NSE : DRREDDY]
Y-o-Y | -2.65 % |
5 Yr CAGR | 12.51 % |
Years | Operating Profit | % Change | |
---|---|---|---|
Mar2023 | ₹3,767 Cr | -2.65 | |
Mar2022 | ₹3,870 Cr | 56.65 | |
Mar2021 | ₹2,470 Cr | -22.27 | |
Mar2020 | ₹3,178 Cr | 35.17 | |
Mar2019 | ₹2,351 Cr | - |
Operating Margins | |
---|---|
Y-o-Y | -13.93 % |
5 Yr CAGR | 1.53 % |
Years | Operating Margin% | % Change | |
---|---|---|---|
Mar2023 | 17.49% | -13.93 | |
Mar2022 | 20.32% | 44.11 | |
Mar2021 | 14.1% | -31.45 | |
Mar2020 | 20.57% | 24.97 | |
Mar2019 | 16.46% | - |
DR REDDYS LABORATORIES Profit After Tax
[BOM: 500124|NSE : DRREDDY]
Y-o-Y | 11.83 % |
5 Yr CAGR | 23.22 % |
Years | Profit After Tax | % Change | |
---|---|---|---|
Mar2023 | ₹2,183 Cr | 11.83 | |
Mar2022 | ₹1,952 Cr | -3.67 | |
Mar2021 | ₹2,026 Cr | 3.90 | |
Mar2020 | ₹1,950 Cr | 105.96 | |
Mar2019 | ₹947 Cr | - |
PAT Margins | |
---|---|
Y-o-Y | 80.36 % |
5 Yr CAGR | 9.69 % |
Years | PAT Margin(%) | % Change | |
---|---|---|---|
Mar2023 | 18.27 % | 80.36 | |
Mar2022 | 10.13 % | -1.17 | |
Mar2021 | 10.25 % | -11.41 | |
Mar2020 | 11.57 % | -8.32 | |
Mar2019 | 12.62 % | - |
DR REDDYS LABORATORIES Earnings Per Share (EPS)
[BOM: 500124|NSE : DRREDDY]
Y-o-Y | 106.27 % |
5 Yr CAGR | 23.19 % |
Years | EPS | % Change | |
---|---|---|---|
Mar2023 | ₹271 | 106.27 | |
Mar2022 | ₹131 | 11.83 | |
Mar2021 | ₹117 | -3.79 | |
Mar2020 | ₹122 | 3.77 | |
Mar2019 | ₹117 | - |
DR REDDYS LABORATORIES Return on Capital Employed (ROCE)
[BOM: 500124|NSE : DRREDDY]
Y-o-Y | 79.71 % |
5 Yr CAGR | 17.71 % |
Years | ROCE | % Change | |
---|---|---|---|
Mar2023 | 26.22% | 79.71 | |
Mar2022 | 14.59% | -5.81 | |
Mar2021 | 15.49% | 39.30 | |
Mar2020 | 11.12% | -18.59 | |
Mar2019 | 13.66% | - |
DR REDDYS LABORATORIES Share Price vs Sensex
Current Share Price | : | ₹5,879.1 |
Current MarketCap | : | ₹ 98,062.6 Cr |
Updated EOD on | : | May 09,2024 |
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -7.4% |
-4.8% |
22.7% |
SENSEX | -3% |
-2.5% |
17.3% |
DR REDDYS LABORATORIES related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE LOW VOLATILITY | -2.6% | -1.6% | 34.2% |
S&P BSE 100 ESG INDEX | -2.7% | -1.4% | 19.4% |
S&P BSE CARBONEX | -3% | -1.7% | 24.6% |
S&P BSE 100 LARGECAP TMC | -3.1% | -1.9% | 25.4% |
S&P BSE SENSEX50 | -3.1% | -2.5% | 20.1% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY ALPHA QTY LOW-VOLAT.30 | 1.6% | 1.7% | 48.5% |
NIFTY ALPHA QTY VAL LOW-VOL 30 | 1.5% | 3% | 60% |
NIFTY GROWTH SECTOR 15 | 1.2% | 11.6% | 9.1% |
NIFTY QUALITY LOW-VOLATILTY 30 | 1.1% | 0.1% | 29.4% |
NIFTY 100 ALPHA 30 | -1.2% | 0.8% | 66.8% |
You may also like the below Video Courses
FAQ about DR REDDYS LABORATORIES Financials
How the annual revenues of DR REDDYS LABORATORIES have changed ?
The Revenues of DR REDDYS LABORATORIES have increased by 13.11% YoY .
How the Earnings per Share (EPS) of DR REDDYS LABORATORIES have changed?
The Earnings Per Share (EPS) of DR REDDYS LABORATORIES has increased by 106.27 % YoY .
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs